Cannabinoid Receptor Agonist Tocriset™
Discontinued ProductUnfortunately Cannabinoid Receptor Agonist Tocriset™ (Cat. No. 2179) has been withdrawn from sale for commercial reasons.
Contains the listed products as lyophilised solids which can be used to activate cannabinoid CB1 and CB2 receptors.
Tocrisets contain 3-5 ligands supplied as lyophilized solids or pre-dissolved in DMSO at a specified concentration. Lyophilized solids have been freeze-dried (approximately 0.5-2 mg per vial) so that addition of 0.5 or 1 ml of solvent produces a stock concentration of 10 or 5 mM respectively.
Please see individual product listings for specific technical data and certificate of analysis.
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
References are publications that support the products' biological activity.
Keywords: Cannabinoid Receptor Agonist TocrisetTM, supplier, Tocris Bioscience
Citations for Cannabinoid Receptor Agonist Tocriset™
Citations are publications that use Tocris products.
Currently there are no citations for Cannabinoid Receptor Agonist Tocriset™.
Reviews for Cannabinoid Receptor Agonist Tocriset™
There are currently no reviews for this product. Be the first to review Cannabinoid Receptor Agonist Tocriset™ and earn rewards!
Have you used Cannabinoid Receptor Agonist Tocriset™?
Submit a review and receive an Amazon gift card.
$10US/$10CAN/€7/£6 gift card for a review without an image
$25US/$25CAN/€18/£15 gift card for a review with an image
*Offer only valid in the USA / Canada, UK and EuropeSubmit a Review